Terada, Akihide
Fujimoto, Kenji
Kise, Kazuyoshi
Fujiwara, Kenta
Uchino, Eiichiro
Mizuma, Yutaka
Nishioku, Yoshinori
Takahashi, Kenzo
Itoh, Ken
Mikami, Tatsuya
Murashita, Koichi
Nakaji, Shigeyuki
Fujita, Yukihiro
Okuno, Yasushi
Tamada, Yoshinori
Article History
Received: 16 March 2025
Accepted: 6 August 2025
First Online: 21 August 2025
Declarations
:
: Y.T. and Y.O. have patent JP7478408 for the method to identify sample (participant)-specific network profiles, that is, ECvs, RC values, and PathRC values, used in this study. K.K., K.F. (Kenta Fujiwara), Y.M., Y.N., and K.T. are employees of Taisho Pharmaceutical Co. Ltd. Taisho Pharmaceutical Co., Ltd. funded the Department of Precision Health Care, Graduate School of Medicine, Hirosaki University, to which K.K., K.F. (Kenta Fujiwara), Y.M., Y.N., K.T., K.I., T.M., K.M., S.N., and Y.T. belong. Value HR Co., Ltd. and Tokio Marine Holdings, Inc. funded the Department of Healthy Life Expectancy Extension Science, Graduate School of Medicine, Hirosaki University, to which K.F. (Kenji Fujimoto), K.I., T.M., and Y.T. belong. Other authors declare no competing interests.